Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 16,136 |
|
|||||
| News | - | ||||||
| Day High | 0.99 | Low High |
|||||
| Day Low | 0.94 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| MiNK Therapeutics Inc | INKT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0241 | -2.49% | 0.9453 | 10:42:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.99 | 0.94 | 0.99 | 0.9694 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 231 | 16,136 | US$ 0.9825177 | US$ 15,854 | - | 0.75 - 3.34 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:05:29 | 1 | US$ 0.99 | USD |
MiNK Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 32.79M | 34.52M | - | 0 | -22.46M | -0.65 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiNK Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INKT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.90 | 0.99 | 0.88115 | 0.9566233 | 48,976 | 0.0453 | 5.03% |
| 1 Month | 1.40 | 1.90 | 0.86 | 1.29 | 161,281 | -0.4547 | -32.48% |
| 3 Months | 0.89 | 1.90 | 0.78 | 1.19 | 98,451 | 0.0553 | 6.21% |
| 6 Months | 1.04 | 1.90 | 0.75 | 1.11 | 72,751 | -0.0947 | -9.11% |
| 1 Year | 0.92 | 3.34 | 0.75 | 1.52 | 92,197 | 0.0253 | 2.75% |
| 3 Years | 12.04 | 22.155 | 0.75 | 3.07 | 112,546 | -11.09 | -92.15% |
| 5 Years | 12.04 | 22.155 | 0.75 | 3.07 | 112,546 | -11.09 | -92.15% |
MiNK Therapeutics Description
| MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses. |
